FDA approves Focused Cold Therapy (myoscience) for patients with Peripheral Nerve Pain

The FDA has approved Focused Cold Therapy, from myoscience, for the treatment of Peripheral Nerve Pain. Focused Cold Therapy relies upon the science of cryoneuromodulation to precisely deliver cold to peripheral nerve tissue. It uses a device that resembles a magic marker pen, but which uses small needles to inject cryogenic material directly into the skin where it disrupts nerve signals. Focused Cold Therapy is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions.